12:00 AM
 | 
Nov 12, 2012
 |  BC Week In Review  |  Clinical News  |  Clinical Status

OMS824: Phase I started

Omeros began a dose-ranging Phase I trial to evaluate OMS824 in healthy volunteers.

Omeros...

Read the full 54 word article

User Sign in

Trial Subscription

Get a 4-week free trial subscription to BioCentury Week In Review

Article Purchase

$30 USD
More Info >